Caxton Associates LP Glaukos Corp Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$47.43 - $84.23 $245,307 - $435,637	-5,172 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$73.06 - $97.7 $377,866 - $505,304	5,172 New	5,172 $439,000
Q2 2020 Aug 14, 2020	SELL	$28.78 - $46.83 $214,871 - $349,632	-7,466 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$25.53 - $70.14 $190,606 - $523,665	7,466 New	7,466 $230,000

303

47M

75.3K

157K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.2B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.